A Platform Trial for Gram Negative Bloodstream Infections — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Platform Trial for Gram Negative Bloodstream Infections — Stella

Recruiting

Back to Gram-negative Bacteremia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(39 sites)

Australia

St George Hospital, Kogarah, New South Wales

John Hunter Hospital, New Lambton, New South Wales

Royal Brisbane and Women's Hospital, Herston, Queensland

Redcliffe Hospital, Redcliffe, Queensland

Sunshine Coast University Hospital, Sunshine Coast, Queensland

Key details

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

Canadian Institutes of Health Research (CIHR), Clínica Universidad de La Sabana

Enrollment target

~2,500 participants

Started

April 2024

Primary completion

April 2027

Age range

0 Years – 130 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.